Vaccine alliance expects to ship 1.4 billion doses by end of the year

The UN-backed program to get vaccines to the neediest people in the world has again scaled back its target, projecting about 1.4 billion doses will available through by the end of the year

Covid-19 vaccines, Coronavirus vaccines, Vaccination
(Photo: Bloomberg)
AP Geneva
2 min read Last Updated : Sep 08 2021 | 10:06 PM IST

The U.N.-backed program to get vaccines to the neediest people in the world has again scaled back its target to ship doses this year, projecting about 1.4 billion doses will available through by the end of the year.

Gavi, the Vaccine Alliance, says the COVAX program that it runs has faced setbacks. Those include export restrictions from hard-hit India, a key producer of vaccines, as well as regulatory hurdles for some vaccine candidates and manufacturing troubles elsewhere.

Still, Gavi says COVAX deliveries are ramping up significantly and another 1.1 billion doses are expected to become available beyond the 330 million doses it has already delivered. Most of the 1.4 billion doses are destined for the poorest developing countries.

Gavi had originally projected 2 billion doses could be shipped through COVAX this year, then in July lowered that projection to about 1.8 billion. Rich countries and others with vaccine production capabilities like Russia and China have already shipped billions of doses to their people, and the World Health Organization has repeatedly insisted that poor countries and health care workers in some places need better access to help stop new variants from emerging.

A top pharmaceutical industry association on Tuesday projected 12 billion doses will be produced this year. However, WHO officials say many are not being shipped where they are needed most.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus VaccineVaccinationVaccine

First Published: Sep 08 2021 | 10:06 PM IST

Next Story